19-19052031-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001199196.2(ARMC6):c.689C>T(p.Thr230Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000663 in 1,613,894 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001199196.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARMC6 | NM_001199196.2 | c.689C>T | p.Thr230Ile | missense_variant | 5/9 | ENST00000535612.6 | NP_001186125.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARMC6 | ENST00000535612.6 | c.689C>T | p.Thr230Ile | missense_variant | 5/9 | 1 | NM_001199196.2 | ENSP00000444156 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152256Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000996 AC: 25AN: 250916Hom.: 0 AF XY: 0.000162 AC XY: 22AN XY: 135758
GnomAD4 exome AF: 0.0000664 AC: 97AN: 1461638Hom.: 1 Cov.: 31 AF XY: 0.0000935 AC XY: 68AN XY: 727118
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152256Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74378
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2023 | The c.689C>T (p.T230I) alteration is located in exon 5 (coding exon 4) of the ARMC6 gene. This alteration results from a C to T substitution at nucleotide position 689, causing the threonine (T) at amino acid position 230 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at